INDO US BIO-TECH LIMITED is a specialized agriculture seed company with its own research station, marketing network and seed production bases. It does import and export of agriculture seeds. It is specialize in the Research and Development, production, Marketing and Sales of all types of Agriculture Seeds. It is also engaged in educating the local farmers by field demonstration of various cultivated crops and giving proper guidance’s to cultivation the crop which having better yield. Company has India’s second and Gujarat’s first seed testing Laboratory and an opportunity to hold a leading positing in acquiring the authorization of ISO 9001-2008 certificate of agriculture seed industry and has been registered as a member of National Seed Association of India.
INDO US BIO-TECH is a small-cap stock with a market capitalisation of Rs 300 crore. The promoters hold 70.17% of the equity capital. The stock has been a scorching multibagger with return of 612%. In just the last month, the stock is up 100%.
The reason for the euphoria is because the company board has declared bonus shares in 1:1 ratio which means that one bonus share will be issued to holding one equity share of the company on record date i.e. 29th August 2023.
As regards the question as to whether the stock is a good buy at present, an expert stated that the stock is very overheated at present. Investors who have bought the stock at lower levels are likely to book their gains as soon as the stock becomes ex-bonus. He advised that we keep the stock in our radar and monitor the fundamental performance for the quarter ended September 2023 an then take a decision on whether or not to invest in INDO US BIO-TECH.